Abstract
Our institution’s student-run free clinic has been able to offer medication at no out-of-pocket cost to all patients since it opened in 2004. We have employed two strategies to manage prescription drug costs while simultaneously increasing medication coverage: (1) using Patient Drug Assistance Programs (PDAPs) and (2) developing an institutional-level partnership with pharmaceutical charities for medication subsidization. In this study, we aimed to analyze the financial impact of these measures on the clinic.
A query of clinic data over the past 5 years identified 299 active PDAPs, corresponding to 299 fully-subsidized prescriptions. In 2017, there were 35 active PDAPs, increasing to 52 (2018), 62 (2019), and 82 (2020) before a decline to 68 PDAPs in 2021. The company affiliated with the most PDAPs varied annually: GlaxoSmithKline (2017), Lilly (2018, 2019, 2020), and both GlaxoSmithKline and Lilly (2021). The most frequent medications were sitagliptin (2017), insulin (2018, 2019), albuterol (2017, 2018), and dulaglutide (2020, 2021).
In addition, data extracted from the private company subsidization program was analyzed for the year 2021. Program membership was $10,000 for institution-wide medication subsidization for all uninsured patients in the hospital system. In total, the clinic was able to acquire 220 medications with a 96% subsidy, corresponding to a direct clinic cost of $2,101.28. Comparatively, the market value of these medications was $52,401.51.
Utilization of free drug acquisition programs and partnerships with pharmaceutical charities allowed for an increase in cost-savings and medications provided. Although the process for applying for medication assistance programs is complex, these programs serve as powerful tools for providing medications that may otherwise be unavailable due to cost. Other clinics and healthcare settings with uninsured patients should consider these programs as a means to ease medication cost burden.
Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Similar content being viewed by others
Abbreviations
- EHHOP:
-
East Harlem Health Outreach Partnership
- GSK:
-
GlaxcoSmithKline
- J&J:
-
Johnson and Johnson
- NYC:
-
New York City
- PDAP:
-
Patient Drug Assistance Program
References
Donohue, J. M.et al., (2011). “Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression,“ Am J Geriatr Psychiatry, vol. 19, no. 12, pp. 989 – 97, Dec https://doi.org/10.1097/JGP.0b013e3182051a9b
Piette, J. D., Wagner, T. H., Potter, M. B., & Schillinger, D. (Feb 2004). Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Medical Care, 42(2), 102–109. https://doi.org/10.1097/01.mlr.0000108742.26446.17
Fernandez-Lazaro, C. I., Adams, D. P., Fernandez-Lazaro, D., Garcia-Gonzalez, J. M., Caballero-Garcia, A., & Miron-Canelo, J. A. (Jun 2019). Medication adherence and barriers among low-income, uninsured patients with multiple chronic conditions. Res Social Adm Pharm, 15(6), 744–753. https://doi.org/10.1016/j.sapharm.2018.09.006
Choudhry, N. K. “Full coverage for preventive medications after myocardial infarction,“ N Engl J Med, vol. 365, no. 22, pp. 2088-97, Dec 1 2011, https://doi.org/10.1056/NEJMsa1107913
Afendulis, C. C., He, Y., Zaslavsky, A. M., & Chernew, M. E. (Aug 2011). The impact of Medicare Part D on hospitalization rates. Health Services Research, 46(4), 1022–1038. https://doi.org/10.1111/j.1475-6773.2011.01244.x
Hinterland, K., et al. (2018). Community health profiles 2018. Brooklyn Community District, 17, 1–20.
Jaya, B. “Containing Prescription Drug Costs at a Resource-Limited, Student-Run Clinic for the Uninsured,“ Journal of Student-Run Clinics, vol. 3, no. 1, 08/27 2017. [Online]. Available: https://journalsrc.org/index.php/jsrc/article/view/59
Acknowledgements
We would like to thank the Pharmacy Head of Mount Sinai, Susan Mashni.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
None.
IRB Approval Status
Not applicable.
Reprint Requests
None.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
He, C., Kalagara, R., Chennareddy, S. et al. Controlling Pharmaceutical Costs in a Student-Run Free Clinic in a Resource-Limited Patient Setting. J Community Health 48, 913–918 (2023). https://doi.org/10.1007/s10900-023-01232-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10900-023-01232-6